
Pharma Prescribed with Leigh Fell, CEO of Caritas Bioscience; The Caritas Effect: Transforming Pharma, shaping biotech's next chapter
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
このコンテンツについて
I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.
In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?
Leigh Fell—a trailblazer in clinical research, a champion of corporate wellbeing, and the visionary founder of Caritas Science Solutions. Leigh’s journey from managing oncology trials to building a purpose-driven CRO is a masterclass in blending scientific rigor with human-centered leadership.
With a degree in Physiology, Sport Science & Nutrition from the University of Glasgow, Leigh began her career running clinical trials for cancer therapies.
In 2017, she launched Caritas with a bold mission: to create a company that not only advances medicine but also nurtures its people. Today, Caritas specializes in trials for brain disorders and oncology, partnering with pharma innovators to address areas of profound unmet need.
Leigh’s leadership philosophy—what she calls corporate athleticism—has led to a 30% increase in employee retention and a culture where wellness and performance go hand in hand.
That ethos earned her a place in The Sunday Times feature on “25 Women Succeeding in 2025”—a spotlight on visionary leaders shaping the future of business, science, and society with purpose and resilience.
But Leigh’s impact goes beyond metrics. She’s redefining what it means to lead in life sciences: integrating yoga, marathon training, and mindfulness into the rhythm of business. Her belief? That building a company is like training for endurance—requiring discipline, resilience, and heart.